EDELWEISS DR ag

Edelweiss DR ag specializes in custom-made dental composite resin kits. These are primarily used for dental restorations and cosmetic applications, such as filling cavities, repairing teeth, or enhancing dental aesthetics. The company’s products include composite resins for general body restorations, flowable body formulations (for easier application), and specialized shades like skin tones and translucent variants. These materials are designed to blend seamlessly with natural teeth.

Edelweiss DR ag is based in the United States. Since the company operates within the U.S., its devices must comply with U.S. medical device regulations, including those set by the FDA. The regulatory framework ensures that dental composite resins—classified as Class II devices—meet safety, performance, and labeling requirements before they are marketed. Compliance involves adhering to FDA guidelines for manufacturing, testing, and post-market surveillance.

Edelweiss DR ag’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system assigns a unique product identifier to each device, enabling better tracking, traceability, and transparency in the medical device supply chain. Listing in the UDI database helps healthcare providers, regulators, and other stakeholders verify the identity and regulatory status of the company’s dental composite resin kits.

Edelweiss DR ag’s dental composite resin kits are classified as FDA Class II devices. This classification is determined based on the level of risk associated with the product. Class II devices generally require special controls in addition to general controls to ensure their safety and effectiveness. These controls may include performance standards, post-market surveillance, or labeling requirements to mitigate potential risks, such as allergic reactions or improper application.